Schroder Investment Management Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Schroder Investment Management Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-176,277	Closed	-$6.58M	–	1589
2021 Q2	$6.58M	Sell	176,277 -118,777	-40%	-$3.64M	0.01%	772
2021 Q1	$7.54M	Buy	295,054 +55,661	+23%	+$1.42M	0.01%	727
2020 Q4	$5.27M	Buy	239,393 +4,455	+2%	+$98.1K	0.01%	790
2020 Q3	$4.25M	Buy	234,938 +15,424	+7%	+$319K	0.01%	753
2020 Q2	$5.58M	Sell	219,514 -9,525	-4%	-$205K	0.01%	662
2020 Q1	$4.54M	Buy	229,039 +119,349	+109%	+$2.32M	0.01%	684
2019 Q4	$2.42M	Buy	109,690 +1,956	+2%	+$39.4K	﹤0.01%	858
2019 Q3	$1.64M	Buy	+107,734	New	+$1.54M	﹤0.01%	918

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Schroder Investment Management Group's DRNA Position: Q3 2021 in Review

Schroder Investment Management Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 176,277 shares — an estimated $6.58M sold.

Schroder Investment Management Group first reported a position in DRNA in Q3 2019 and held it in 8 quarters. The position peaked at $7.54M in Q1 2021. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

Schroder Investment Management Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Schroder Investment Management Group sold 176,277 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $6.58M.
Schroder Investment Management Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2019 and held it in 8 quarters.
Schroder Investment Management Group's Dicerna Pharmaceuticals, Inc. position peaked at $7.54M in Q1 2021.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on Schroder Investment Management Group's 13F filing for Q3 2021, filed 12 Nov 2021.